Why Pharma Needs Domain-Native AI, Not Generic Chatbots
As pharmaceutical companies move from generative AI pilots to enterprise adoption, the bigger challenge is no longer access to powerful models. It is whether the data, workflows, governance, and decision context that define how pharma operates are ready for AI usage.


